Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody-Reference-Cited by-同舟云学术

Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody

Published:2013-07-30 Issue:10 Volume:104 Page:1330-1338
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Wen Feng¹,Tang Ruilei¹,Sang Yaxiong²,Li Meng²,Hu Qiancheng¹,Du Zedong³,Zhou Yi¹,Zhang Pengfei¹,He Xiaofeng,Li Qiu¹

Affiliation:

1. Department of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, Sichuan; China

2. State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, Sichuan; China

3. Department of Oncology; 363 Hospital; Chengdu, Sichuan; China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12224/fullpdf

Reference55 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Colorectal cancer;Weitz;Lancet,2005

3. Anti-EGFR Monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab;You;J Clin Pharmacol,2011

4. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts;Prewett;Clin Cancer Res,2002

5. Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?;Peeters;Oncologist,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of the Infusion Order in the Treatment of Cancer;Chemotherapy Protocols and Infusion Sequence;2022

2. The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the ‘unexplainable’;Personalized Medicine;2018-07-01

3. FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer;Medicine;2018-03

4. A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study);Clinical Colorectal Cancer;2016-12

5. Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer;World Journal of Gastroenterology;2016